Thomas H. Adams

Thomas H. Adams

Plus aucun poste en cours

81 ans
Health Technology
Commercial Services
Electronic Technology

Profil

Thomas H.
Adams
was the founder of Gen-Probe, Inc. (1983) and Genta, Inc. (1989) where he held the titles of Chairman & Chief Executive Officer.
He also held former positions as Chairman & Chief Executive Officer of Leucadia Technologies, Inc. (1998-2006), Iris Molecular Diagnostics, Inc. (2005-2012), and Clearbridge Biophotonics, Inc. (2013-2019).
Additionally, he served as a Director for various companies including Life Technologies, Inc. (1992-2001), La Jolla Pharmaceutical Co. (1990-2009), and Alere San Diego, Inc. (1989-1998).
He holds a doctorate degree from the University of California, Riverside.

Anciens postes connus de Thomas H. Adams

SociétésPosteFin
Director/Board Member 09/01/2022
Chief Executive Officer 09/01/2022
Director/Board Member 09/01/2022
HEPION PHARMACEUTICALS, INC. Director/Board Member 09/01/2022
CARDIFF ONCOLOGY, INC. Chief Executive Officer 08/05/2020
Voir l'expérience en détail de Thomas H. Adams

Formation de Thomas H. Adams

University of California, Riverside Doctorate Degree

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Thomas H. Adams

Relations

100 +

Relations au 1er degré

22

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées2
HEPION PHARMACEUTICALS, INC.

Health Technology

CARDIFF ONCOLOGY, INC.

Health Technology

Entreprise privées19

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

Electronic Technology

Health Technology

Health Technology

Pawfect Foods, Inc.

Retail Trade

Clearbridge Biophotonics, Inc.

Technology Services

Health Technology

Commercial Services

Health Technology

Baxter Laboratories, Inc.

IRIS Personalized Medicine, Inc.

Health Technology

Health Technology

Health Technology

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. Thomas H. Adams